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Abstract
Background: Longitudinal studies of HIV-1-infected individuals or those at risk of infection are subject to missed study visits
that may have negative consequences on the care of participants and can jeopardize study validity due to bias and loss of
statistical power. Distance between participant residence and study clinic, as well as other socioeconomic and demographic
factors, may contribute to interruptions in patient follow-up.
Methods: HIV-1-serodiscordant couples were enrolled between May 2007 and October 2009 and followed for two years in
Nairobi, Kenya. At baseline, demographic and home location information was collected and linear distance from each
participant’s home to the study clinic was determined. Participants were asked to return to the study clinic for quarterly
visits, with follow-up interruptions (FUI) defined as missing two consecutive visits. Cox proportional hazards regression was
used to assess crude and adjusted associations between FUI and home-to-clinic distance, and other baseline characteristics.
Results: Of 469 enrolled couples, 64% had a female HIV-1-infected partner. Overall incidence of FUI was 13.4 per 100
person-years (PY), with lower incidence of FUI in HIV-1-infected (10.8 per 100 PY) versus -uninfected individuals (16.1 per
100 PY) (hazard ratio [HR]=0.66; 95% confidence interval [CI]: 0.50, 0.88). Among HIV-1-infected participants, those living
between 5 and 10 kilometers (km) from the study clinic had a two-fold increased rate of FUI compared to those living
,5 km away (HR=2.17; 95% CI: 1.09, 4.34). Other factors associated with FUI included paying higher rent (HR=1.67; 95% CI:
1.05, 2.65), having at least primary school education (HR=1.96; 95% CI: 1.02, 3.70), and increased HIV-1 viral load
(HR=1.23 per log10 increase; 95% CI: 1.01, 1.51).
Conclusions: Home-to-clinic distance, indicators of socioeconomic status, and markers of disease progression may affect
compliance with study follow-up schedules. Retention strategies should focus on participants at greatest risk of FUI to
ensure study validity.
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Introduction
Missing data resulting from participant attrition, or incomplete
study follow-up, threaten the integrity of a study, with
consequences ranging from a reduction in statistical power to
significantly biased results and diminished validity. While
numerous techniques have been developed to address the
problem, none are simple, most require manipulation of the
data, and the precision of results can be difficult to determine [1–
7]. Missing data could be reduced or preemptively addressed by
predicting which participants are most likely to miss visits or be
lost to follow-up. Eligibility criteria can be designed to limit
enrollment to those with more adherent profiles and supplemen-
tal support procedures can be implemented to improve contact
with those most at risk of follow-up interruptions.
Predicting attrition is challenging and has been the subject of a
number of studies in the U.S., Western Europe and sub-Saharan
Africa. Reviews of published studies have listed up to 18 different
definitions for patients who were considered lost to follow-up [8,9],
ranging from missed visits to complete disappearance from a
study. Despite varying operational definitions of study attrition,
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rates, specifically those that have a longer duration of follow-up
[10] or frequent, complex or time-consuming visits [1,11,12]. The
use of unskilled or inconsistently trained staff and the provision of
limited incentives also lead to higher attrition [11,13]. Participant
characteristics also appear to play an important role in the
likelihood of follow-up interruption. In the US, characteristics of
study participants at risk for attrition include lower income [13],
less education [13], black race [1,13], lower CD4 count [1,10],
younger age [1,10,14,15], hospitalization or incarceration [16],
injection drug use [1,10,16], unwillingness to travel [16], and
increased life stressors, multiple health problems and inconsistent
use of health care resources [1,11]. Gender differences in rates of
missed visits have been inconclusive [1,11,13,15].
In sub-Saharan Africa and other resource-limited settings,
reasons for not completing a study are not fully understood.
Despite the paucity of data on the subject, some factors have been
associated with attrition in antiretroviral treatment (ART)
programs in sub-Saharan Africa, including younger age [17–19],
baseline CD4 cell count [18,20–22] and male gender
[17,18,20,22,23]. Many of the retention difficulties described by
patients are similar to those listed by study participants in the
United States, including health problems [17,24], concurrent
family and/or work commitments [25,26], limited clinic hours
[25], long appointments [25–27], lack of child care [8], and lost
wages or employment [25,26,28]. Cultural or socio-economic
factors may pose considerable difficulty for study participants with
HIV in Africa. These include fear of disclosure of HIV status
[27,29], bias of family and friends against study participation [30],
spousal abuse [29], stigma [26,27], and the financial costs
associated with the program [26–28,31,32], particularly those
relating to transportation [24,27,29,32,33].
Distance-decay is used to explain how health care use is
negatively correlated with the distance patients must travel to
access care [34–36]. Specifically, distance-decay implies that
patients who must travel greater distances may delay seeking
health care and have worse outcomes [37]. Research studies often
require multiple study visits at a higher frequency than routine
care, and similar effects of travel distance on adherence to visit
schedules may also occur in research settings. To examine this
possibility and assess other correlates of poor adherence to study
visits, we used follow-up records from a prospective cohort study of
HIV-1-discordant couples conducted in Nairobi, Kenya to
determine whether the distance between a participant’s home
and the research clinic was an important factor in explaining
missed study visits.
Methods
Ethics Statement
Written informed consent was obtained from all participants.
This study received ethical approval from the institutional review
board of the University of Washington and the Ethics and
Research Committee of the University of Nairobi and was
conducted according to the guidelines set forth by the United
States Department of Health and Human Services.
Recruitment and Enrollment
HIV-1-serodiscordant heterosexual couples were enrolled in a
prospective cohort study between May 2007 and October 2009.
Couples were eligible if one member of the couple was HIV-1-
infected and the other HIV-1 susceptible, both partners reported
having sexual intercourse at least 3 times in the previous 3 months,
and planned to stay together for at least two years. Participants
who were pregnant or using antiretroviral therapy at enrollment
were excluded.
Couples were referred to the study from HIV voluntary
counseling and testing (VCT) sites throughout the greater Nairobi
region and from a clinical trial site at Kenyatta National Hospital
that had identified discordant couples. Couples provided written
informed consent at the screening and enrollment visits as well as
contact and locator information for retention-tracking purposes.
All couples received at least one home visit from a peer counselor
to verify the location of their residence. Study clinicians collected
baseline sociodemographic, sexual/reproductive and medical
history data from both members of the couple, and blood and
genital samples were collected at screening, enrollment and
subsequent visits.
Study Follow-up Visits
Couples were asked to return to the study clinic quarterly to
provide blood and genital specimens, complete questionnaires on
recent sexual behavior and current health status, and be tested for
HIV-1 seroconversion. HIV-1-infected partners were supplied
with trimethoprim-sulfamethoxazole to be taken daily as prophy-
laxis for opportunistic infections. Couples continued to be followed
in the study even if they separated, the female partner became
pregnant, or one partner left the study.
Support groups for those with and without HIV infection were
available throughout the study. Drinks were supplied free of
charge during clinic visits, and participants were reimbursed 500
Kenyan Shillings (KSh), (approximately 3.50 US dollars [USD])
per visit for transportation expenses to and from the clinic.
Laboratory Procedures
At enrollment and quarterly visits, HIV status of the uninfected
partner was determined by two rapid tests conducted in parallel
using the Determine HIV-1/2 rapid test (Abbott Laboratories,
Tokyo, Japan, now marketed by Inverness Medical as Alere
Determine) and the Bioline HIV 1/2 rapid test (Standard
Diagnostics Inc., Suwon, Korea), with confirmation by the
Vironostika HIV Uni-form II Ag/Ab ELISA kit (bioMe ´rieux
SA, Marcy l’Etoile, France) for positives or indeterminates. Urine
pregnancy tests were also performed every three months (Quick
Vue One Step hCG Urine Pregnancy kit, Quidel Corp, San
Diego, CA). CD4 cell counts (FACSCaliber, BS Bioscience,
Franklin Lakes, USA) and HIV-1 RNA viral load (Gen-Probe
Transcription Mediated Amplification, San Diego, USA) were
measured in HIV-1-infected participants at enrollment and every
six months.
Geographic Mapping
The locations of participants’ residences were mapped using
locator information provided by each participant. Based on this
information, a member of the study retention team mapped each
residence using a web-based mapping application built on the
Google Maps engine (Google, Inc, Mountain View, CA). The
geographic coordinates for all VCT sites and the study clinic were
determined using a handheld global positioning system (GPS) unit
(Trimbel Juno, Sunnyvale, USA). The resulting coordinates were
used to estimate linear (as the crow flies) distances between each
residence and the referring VCT and between each residence and
the study clinic using a geospatial algorithm (Google, Inc).
Statistical Analysis
The outcome in this analysis was time until study follow-up
interruption (FUI), defined as missing two consecutive quarterly
Follow-Up Interruptions in HIV-Discordant Couples
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evaluate the time from enrollment until the first FUI, calculated as
the length of time between the date of the enrollment visit and the
scheduled date of the first missed visit (three months after the last
completed clinic visit). Participants were censored at the date for
their last scheduled follow-up visit, or at the date of death for
participants who died during follow-up. If the exact date of death
was unknown, the censoring date was defined as three months
after the last completed visit. The crude associations between FUI
and factors of interest were estimated by hazard ratios (HR) and
95% confidence intervals (CI). We hypothesized a priori that HIV
status would modify the associations between FUI and distance
variables, and therefore all analyses were conducted separately for
HIV-1-infected and HIV-1-uninfected individuals. For regression
models, distance was considered both continuously and categor-
ically. We assumed that distances beyond 5 kilometers (km) were
likely to necessitate transport other than walking, and therefore
categorized linear distance into 5 km intervals (0–5, 5–10, 10–15,
and .15). Potential confounders were included stepwise in a
multivariable model and remained in the model if the adjusted
association differed from the unadjusted hazard ratio by more
than 10% in either the HIV-1-infected or -uninfected model.
Robust standard errors were used to relax the assumption of
normally distributed standard errors. All statistical analyses were
conducted in Stata 10.1 (StataCorp, College Station, TX) with
statistical significance criteria set at a,0.05.
Results
Study Population and Cohort Characteristics
Four hundred sixty nine HIV-1-discordant couples (938
individuals) were enrolled into the study. The male member of
the couple was HIV-1-infected in 168 (36%) of enrolled couples,
and the female was the infected partner in 301 (64%) of the
couples. Median CD4 cell count at baseline in the HIV-1-infected
was 415 cells/ml (Interquartile Range [IQR]: 281, 618) and
median HIV-1 viral load was 4.6 log10 copies/ml (IQR: 3.9, 5.3).
Among all enrolled, the median age at enrollment was 35 years
Table 1. Baseline characteristics of study participants.
Couples with HIV-1-Infected Male Partner Couples with HIV-1-Infected Female Partner
HIV-1-Infected HIV-1-Uninfected HIV-1-Uninfected HIV-1-infected
Male Female Male Female
N=168 N=168 N=301 N=301
Characteristic median (IQR) or n (%)
Age (Years) 36 (32, 42.5) 29 (25, 35) 34 (29, 39) 28 (24, 34)
Relationship duration (years) 6.3 (2.4, 10.9) 5.8 (2.4, 11.2) 4.77 (2.4, 9.5) 4.8 (2.3, 8.7)
CD4 Count (cells/ml) 340.5 (231, 503) – – 476 (307.5, 673)
HIV-1 Viral Load (Log10 copies/mL) 4.8 (4.1, 5.4) – – 4.6 (3.7, 5.2)
Home-to-clinic distance (km)
a
0–4.9 36 (21.8) 36 (21.8) 58 (19.3) 58 (19.3)
5–9.9 55 (33.3) 55 (33.3) 114 (37.9) 114 (37.9)
10–14.9 46 (27.9) 46 (27.9) 77 (25.6) 77 (25.6)
$15 28 (17.0) 28 (17.0) 52 (17.3) 52 (17.3)
Married to Study Partner 165 (98.2) 162 (97.0) 289 (96.0) 284 (94.7)
Number of Living Children
0 13 (7.7) 18 (10.7) 42 (14.0) 37 (12.3)
1–2 81 (48.2) 86 (51.2) 164 (54.5) 180 (59.8)
$3 74 (44.1) 64 (38.1) 95 (31.6) 84 (27.9)
Less than Primary school education 25 (14.9) 45 (26.8) 45 (15.0) 71 (23.6)
Informal Residence 85 (50.6) 83 (49.4) 153 (50.8) 161 (53.7)
Home Ownership/Rent
Rent , KSh 2,000
b 66 (39.3) 66 (39.3) 134 (44.5) 138 (45.9)
Rent $ KSh 2,000 87 (51.8) 87 (51.8) 140 (46.5) 140 (46.5)
Own home 15 (8.9) 15 (8.9) 27 (9.0) 23 (7.6)
Monthly household income (KSh)
Couple does not earn income 20 (11.9) 20 (11.9) 35 (11.6) 35 (11.6)
Monthly income ,8,000
c 57 (33.9) 57 (33.9) 111 (36.9) 111 (36.9)
Monthly income $8,000 91 (54.2) 91 (54.2) 155 (51.5) 155 (51.5)
NOTE. IQR = interquartile range; KSh = Kenyan Shillings. Monthly household income is the sum of the income for both study partners.
aLinear distance, based on location of residence at enrollment. Data missing for 6 participants.
bBased on the median rent (2,000 KSh < 26 USD).
cBased on the median monthly income (8,000 KSh < 104 USD).
doi:10.1371/journal.pone.0043138.t001
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(Table 1).
A total of 186 (20%) participants had less than a primary school
education: 70 (15%) men and 116 (25%) women. Fifty-five (12%)
of the couples enrolled reported no household income at study
entry, 36% reported earning less than the median of 8,000 KSh
per month, and 197 (52%) earned more than 8,000 KSh per
month, equivalent to approximately 130 USD at the time of the
study. Eighty (9%) participants reported owning a home at study
entry with the remaining 858 (91%) renting their current
residence.
Incidence of Follow-up Interruptions
Of those enrolled, 197 individuals missed two consecutive study
visits and were categorized as having an FUI during 1471 person-
years (PY) of follow-up, for a rate of 13.4 FUI per 100 PY. Among
HIV-1-infected partners 46 women and 35 men experienced FUI
and among HIV-1-uninfected partners, 46 women and 70 men
experienced FUI (Figure 1). The rate of FUI was 10.8 per 100 PY
in the HIV-1-infected and was significantly lower than the rate of
16.1 per 100 PY in the uninfected participants (HR=0.66,
p=0.004). Among the HIV-1-infected, women had a slightly
lower FUI rate than men (9.4 versus 13.2 per 100 PY; HR=0.72,
p=0.138), while among the HIV-1-uninfected, women had a
slightly higher FUI rate than men (18.2 versus 15.0 per 100 PY;
HR=1.22, p=0.229). Among women, the HIV-1-infected had a
significantly lower FUI rate than the uninfected (HR=0.52,
p,0.01). However, among the men, there was no difference in the
FUI rate between HIV-1-infected and -uninfected (HR=0.87,
p=0.485).
Relationship between Home-to-Clinic Distance and FUI
For each couple we ascertained a linear distance between the
residence and the study clinic (Figure 2). Patients lived a median of
9.14 km (IQR: 6.15, 12.79) from the clinic, with three couples
living more than 100 km from the clinic. Eighty-three percent of
couples lived within 15 km of the study clinic, and 20% of couples
lived within 5 km.
Among HIV-1-infected participants, living between 5 and
10 km from the study clinic was significantly associated with a
greater than two-fold increased likelihood of FUI when compared
to those living ,5 km from the clinic (Hazard Ratio [HR] 2.17;
95% CI: 1.09, 4.34; p=0.03) (Table 2). Similar associations were
seen in the 10–15 km (HR: 1.55, 95% CI: 0.74, 3.26; p=0.25)
and .15 km categories (HR: 1.48, 95% CI: 0.66, 3.33; p=0.35),
when compared to the less than 5 km distance category; however,
these did not reach statistical significance. No significant
associations between FUI and home-to-clinic distance were found
among HIV-1-uninfected individuals. Similarly, no associations
between FUI and home-to-clinic distance were found when
distance was considered as a linear variable in the model.
To further investigate the finding that a residence 5–10 km
from the study clinic was the highest risk group among HIV-1-
infected participants, we conducted a series of post-hoc analyses.
We found no significant difference in risk of FUI between HIV-1-
infected participants living $10 km from the clinic compared to
those living 5–10 km (HR=0.70, 95% CI 0.44 to 1.11, p=0.13),
and when we collapsed these categories, there was an attenuated
association between distance from study clinic and FUI
(HR=1.80 comparing $5k mt o,5 km, 95% CI 0.94, 3.47,
p=0.08).
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Figure 1. Cumulative incidence of follow-up interruptions. HIV-1-discordant couples were enrolled and followed quarterly for 2 years. A
follow-up interruption (FUI) was defined as missing $2 consecutive study visits. The Kaplan Meier curves show the cumulative incidence of FUI
separately for (—) HIV-1-uninfected females, (———), -infected females, (—) -uninfected males, and (– – –) -infected males.
doi:10.1371/journal.pone.0043138.g001
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Interruption
We evaluated other sociodemographic factors as potential
correlates of FUI using Cox regression with separate models for
HIV-1-infected and -uninfected participants. Among HIV-1-
infected participants, higher baseline log10 HIV-1 viral load was
associated with increased FUI rates (HR=1.23, 95% CI: 1.01,
1.51), and having less than a primary school education was
associated with lower FUI rates (HR=0.51, 95% CI: 0.27, 0.98).
Also among HIV- infected individuals, paying greater than or
equal to the median monthly rent ($2000 KSh, approximately
26 USD) compared to rent less than the median rent was
associated with a 67% increase in the rate of FUI (95% CI:
1.05, 2.65). We found no significant associations between baseline
characteristics and FUI among HIV-1-uninfected participants. A
multivariable model fit separately for HIV-1-infected and -
uninfected patients including primary school education, monthly
rent and log10 HIV-1 viral load (for the HIV-1 infected group
only) found no independent associations with FUI (data not
shown).
To determine whether gender modified the association between
linear distance and FUI, we stratified the analysis by both gender
and HIV-1 status. Among the HIV-1-positive women, living
between 5 and 10 km from the study clinic was associated with a
nearly three-fold increase in the FUI rate compared to those living
,5 km from the clinic (95% CI: 1.01, 8.61; p=0.05) (Table 3).
Distance categories of 10–15 km and .15 km had increased FUI
rates, but these did not achieve statistical significance (HR=2.04,
p=0.22 and HR=2.45, p=0.14, respectively). Conversely,
among HIV-1-uninfected males, there was a pattern of decreased
FUI with home-to-clinic distances greater than 5 km, but these
associations were not statistically significant. Overall we did not
find that gender modified the association between distance and
FUI; the likelihood ratio test for a distance/gender interaction was
not significant in either HIV-1-infected (p=0.420) or -uninfected
groups (p=0.999). Rent/home ownership was the only confound-
er in the association between distance and FUI. After adjustment
for rent/home ownership, the 5–10 km distance was no longer
statistically significant among the HIV-positive females.
Discussion
In a longitudinal cohort of HIV-1-discordant couples followed
quarterly, we found that rates of FUI were high (21% overall) and
that distance between home and the study clinic was significantly
Figure 2. Map of distances from the study clinic. The map of Nairobi shows the location of the study clinic, with linear distances to the study
clinic indicated by concentric white circles at 5 km increments. The percentage of participants living within each section is shown in yellow.
doi:10.1371/journal.pone.0043138.g002
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While HIV-1-infected female partners were the least likely to miss
two consecutive quarterly visits, they were approximately three
times more likely to experience FUI if they resided greater than
walking distance (.5 km) from the clinic.
We found a complicated relationship between distance from
participants’ residences and the study clinic and their likelihood of
an FUI. The association between home-to-clinic distance and FUI
was restricted to HIV-1-infected participants, and the strongest
association was among those living 5–10 km from the study clinic
with a weaker relationship among those living .10 km from the
clinic. This pattern was stronger among HIV-1-infected women
compared to infected men. Transportation challenges related to
traveling more than 5 km to reach the clinic may pose a barrier to
attending study visits. For example, those living within 5–10 km
from the centrally located study clinic resided within city limits,
potentially resulting in higher transportation costs (approximately
200 KSh per study visit) if they could not walk the distance to
clinic. Participants living ,5 km from the study clinic may have
walked to study visits, or if not, were unlikely to have spent a large
proportion of the compensation on direct transportation costs
(likely less than 60 Ksh). Therefore, the 500 KSh per visit
incentive, an amount equal to a quarter of the median monthly
rent (2,000 KSh), may pose a greater incentive for those residing
closer to the clinic compared to those living at or near the city
limits. We did not find a significant association between longer
home-to-clinic distances (i.e., .10 km) and the risk of FUI.
However, the point estimates for this category were slightly lower
than in the 5–10 km category, and the lack of statistical
significance may simply represent a loss of statistical power. We
hypothesize that those who lived a greater distance from the study
clinic and chose to enroll may have a greater level of motivation to
continue participation, possibly due to a desire to obtain
specialized health care not available near their home or to avoid
stigma related to HIV infection. Additionally, living farther from
the center of town may be indicative of lower socioeconomic status
and increased reliance on the financial reimbursement provided
by the study, and thus decreased rates of FUI.
In this study, we found that women experienced fewer FUI than
men, which is consistent with other studies that have found greater
adherence to clinic visits and less program attrition among HIV-1-
infected women compared to -infected men [8,18,23,38]. It has
been hypothesized that this is due to women’s motivation to
remain healthy for her family [17]. While our study confirmed that
HIV-1-infected women were less likely to miss study visits, we also
found that within this group, home-to-clinic distance may play a
role in FUI. HIV-1-infected women who are otherwise motivated
to adhere to a study visit schedule may find the .5 km distance a
challenge if they begin to experience HIV-related symptoms. A
link between ill health and missed visits is supported by the fact
that a higher viral load at enrollment was a significant predictor of
increased risk of FUI. Higher viral load, a marker for HIV disease
progression, could result in difficulty adhering to scheduled visits
since participants who are ill may be unable to travel or may need
to spend time seeking care and treatment rather than attending
study visits. If antiretroviral treatment is commenced, participants
with poor adherence to their medications may also demonstrate
poor adherence to study visits as well. Additionally, previous
studies have found that women spend more time traveling to
obtain basic needs (e.g., food and water) for their families.
Therefore, a longer distance to reach the study clinic may strain
the physical and time resources of HIV-1-infected women
compared to their male counterparts, resulting in the greater
observed impact of distance on FUI among this group [39,40].
We also found that paying higher rent was associated with a
67% increase in the FUI rate compared to paying lower rent. If a
higher rent is an indicator of greater employment obligations, then
the need to take time off from work to attend study visits may
explain this association. However, since we saw no statistically
significant association between household income and FUI, the
association with rent may be influenced by other factors, such as
the distance between the place of employment and study clinic.
Having less than a primary education was also significantly
associated with nearly half the rate of FUI compared to those with
at least a primary education. Lower levels of education could limit
a person’s ability to find stable employment, which could increase
the need for the financial benefits of participating in a research
study.
This study had several limitations. We were able to obtain
measurements of the distance between participants’ residences and
the clinic; however, we were unable to determine the time or
Table 2. Correlates of study follow-up interruption.
HIV-1-Infected HIV-1-Uninfected
Characteristic HR (95% CI) HR (95% CI)
Female gender 0.72 (0.47, 1.11) 1.26 (0.88, 1.81)
Age 1.00 (0.87, 1.15) 0.95 (0.84, 1.07)
Relationship duration 0.98 (0.94, 1.02) 0.98 (0.95, 1.01)
CD4 count 0.95 (0.88, 1.04) – –
HIV-1 viral load (Log10 copies/mL) 1.23 * (1.01, 1.51) – –
Home-to-clinic distance (km)
a
0–4.9 1 ref 1 ref
5–9.9 2.17 * (1.09, 4.34) 0.81 (0.50, 1.30)
10–14.9 1.55 (0.74, 3.26) 0.67 (0.39, 1.13)
$15 1.48 (0.66, 3.33) 0.88 (0.50, 1.53)
Married to study partner 0.75 (0.27, 2.04) 0.53 (0.25, 1.10)
Number of living children
0 1 ref 1 ref
1–2 0.61 (0.33, 1.15) 0.73 (0.44, 1.22)
$3 0.62 (0.32, 1.20) 0.87 (0.51, 1.47)
Less than primary education 0.51 * (0.27, 0.98) 1.34 (0.88, 2.04)
Informal residence 0.99 (0.65, 1.52) 1.22 (0.86, 1.75)
Own home/monthly rent
Rent , KSh 2,000
b 1 ref 1 ref
Rent $ KSh 2,000 1.67 * (1.05, 2.65) 1.14 (0.78, 1.67)
Own home 1.23 (0.51, 2.97) 1.15 (0.61, 2.18)
Monthly household income (KSh)
Couple does not earn income 1 ref 1 ref
Monthly income ,8,000
c 0.69 (0.36, 1.35) 0.68 (0.39, 1.19)
Monthly income $8,000 0.78 (0.42, 1.46) 0.64 (0.37, 1.09)
NOTE. HR = hazard ratio; CI = confidence interval; KSh = Kenyan Shillings. The
HR for age is per 5 years, the HR for relationship duration is per 1 year, and the
HR for CD4 count is per 100 cells/ml. Monthly household income is the sum of
the income for both study partners. Confidence intervals were calculated using
robust standard errors.
aLinear distance, based on location of residence at enrollment. Data missing for
6 participants.
bBased on the median rent. 2,000 KSh < 26 USD.
c8,000 KSh < 104 USD.
*p,0.05.
doi:10.1371/journal.pone.0043138.t002
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one study, travel cost was found to be significantly associated with
FUI, while the distance was not [41]; in another, travel time and
distance were significantly associated, while cost was not [42].
Also, because this secondary study was conducted retrospectively,
we were unable to assess participant perceptions of the impact of
travel and distance on their ability to adhere to visits, or any other
variables that could have affected study follow-up. In addition, we
were only able to access locator information obtained at the first
clinic visit. As a result, our data did not account for subsequent
changes in residence.
Despite its limitations, our study provides important informa-
tion for further investigation. We found that living further from the
study clinic was not significantly associated with an increased risk
of FUI, with the exception of HIV-1-infected women between 5
and 10 km, indicating that enrollment of participants living far
from the clinic may not be inherently problematic. We also found
that HIV-1-uninfected men and women had higher rates of
interruption of study follow-up and are an important group on
which to concentrate retention efforts in clinical trials and
prospective studies that depend on retaining both HIV-1-infected
and -uninfected participants. In this study, higher rates of FUI
among HIV-1-uninfected partners may have been due to the lack
of direct benefits from attending study visits. Unlike their infected
partners who received CD4 cell count testing and drugs to prevent
opportunistic infections at the study clinic, the uninfected partners
may have experienced limited direct benefits from study partic-
ipation, and consequently may have been less motivated to attend
visits.
There has been limited research on retention of HIV-1-
discordant couples in clinical research studies in sub-Saharan
Africa. Yet these couples bear one of the greatest burdens of HIV
transmission, and are already the focus of several large HIV
prevention studies. Understanding and addressing transportation
challenges in settings without easily accessible and inexpensive
modes transportation could improve retention, both in research
studies as well as in routine care and disease management. Studies
combining quantitative and qualitative methods to address the
barriers and incentives to study retention are needed to improve
study retention and more importantly, to improve utilization and
access to health care in sub-Saharan Africa settings.
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